Finding the Perfect Fit

Branca, Malorye A.
April 2004
Bio-IT World;Apr2004, Vol. 3 Issue 4, p36
Academic Journal
Presents information on the kinase inhibitor, a lead cancer compound delivered by Plexxikon to Genentech. Reaction of researchers to high-throughput screening (HTS); Procedure for finding the perfect fit for the kinase program in HTS libraries; Discussion on companies with positive results on their kinase program.


Related Articles

  • New screening tools for lead compound identification. Sawyer, Tomi K. // Nature Chemical Biology;Aug2005, Vol. 1 Issue 3, p125 

    Describes a new high-throughput assay for the identification of promising lead compounds. Challenges of lead compound generation and optimization to advance drug development; Selection of promising compounds to compete in the race for lead compound optimization; Provision of experimental and...

  • Virtual Screening: Are We There Yet? Jalaie, Mehran; Shanmugasundaram, Veerabahu // Mini Reviews in Medicinal Chemistry;Oct2006, Vol. 6 Issue 10, p1159 

    The cost of pharmaceutical development has increased dramatically in recent years, and many assorted approaches have been developed to decrease both the time and costs associated with bringing a drug to the market. Among these methods is the use of in silico screening of compound databases for...

  • High-Throughput Screening Assays to Discover Small-Molecule Inhibitors of Protein Interactions. Colas, Pierre // Current Drug Discovery Technologies;Sep2008, Vol. 5 Issue 3, p190 

    The availability of large collections of small-molecule inhibitors of protein interactions would bear a tremendous impact both on academic and therapeutic research. The past recent years have seen a marked acceleration in the discovery of protein interaction inhibitors, through structure-based...

  • Screening: Won't get fooled again. Kirkpatrick, Peter // Nature Reviews Drug Discovery;Aug2005, Vol. 4 Issue 8, p630 

    Outlines a study on high-throughput assays that aim to address the problem with prevalence of nonspecific or promiscuous inhibitors, previously published in "Nature Chemical Biology". Explanations for the promiscuous compounds; Rapid assays developed based on a standard 96-well format for...

  • Virtual High Throughput Screening in New Lead Identification. Badrinarayan, Preethi; Sastry, G. Narahari // Combinatorial Chemistry & High Throughput Screening;Dec2011, Vol. 14 Issue 10, p840 

    Drug discovery continues to be one of the greatest contemporary challenges and rational application of modelling approaches is the first important step to obtain lead compounds, which can be optimised further. Virtual high throughput screening (VHTS) is one of the efficient approaches to obtain...

  • A High Throughput Fluorescence Polarization Assay for Inhibitors of the GoLoco Motif/G-alpha Interaction. Kimple, Adam J.; Yasgar, Adam; Hughes, Mark; Jadhav, Ajit; Willard, Francis S.; Muller, Robin E.; Austin, Christopher P.; Inglese, James; Ibeanu, Gordon C.; Siderovski, David P.; Simeonov, Anton // Combinatorial Chemistry & High Throughput Screening;Jun2008, Vol. 11 Issue 5, p396 

    The GoLoco motif is a short G..-binding polypeptide sequence. It is often found in proteins that regulate cell-surface receptor signaling, such as RGS12, as well as in proteins that regulate mitotic spindle orientation and force generation during cell division, such as GPSM2/LGN. Here, we...

  • A Flexible Multiwell Format for Immunofluorescence Screening Microscopy of Small-Molecule Inhibitors. Anne-Kathrin Scholz; Bert M. Klebl; Markus Morkel; Hans Lehrach; Andreas Dahl; Bodo M.H. Lange // Assay & Drug Development Technologies;Oct2010, Vol. 8 Issue 5, p571 

    AbstractLarge-scale screens in mammalian cells demand for flexible high-throughput screening platforms that allow to analyze cellular traits on a genome-wide level or to identify small-molecule inhibitors (SMIs) from complex compound libraries. In this study we developed and tested high-density...

  • Lab-on-a-Chip Technologies Emerging from Infancy. Derra, Skip // Drug Discovery & Development;May2003, Vol. 6 Issue 5, p40 

    Reports on the emergence of lab-on-chip (LOC) technologies for high-throughput screening. Description of commercially available LOC devices; Efforts of LOC developers to expand capabilities of their products. INSET: In Academia, Several Fronts Push Lab-On-Chip Technology.

  • Bridging the Screening Gap.  // Drug Discovery & Development;May2003, Vol. 6 Issue 5, p85 

    Discusses the advantages of high throughput and high-content assays in drug discovery and development. User autonomy; Ability to provide comprehensive level of biological and chemical information needed to reduce late-stage failures; Seamless assay transfer; Lectin binding screen.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics